UBS Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,031
| Closed | -$38.9K | – | 9057 |
|
|
2023
Q1 | $38.9K | Buy |
21,031
+9,204
| +78% | +$17K | ﹤0.01% | 5536 |
|
|
2022
Q4 | $13.1K | Buy |
11,827
+11,596
| +5,020% | +$12.9K | ﹤0.01% | 7007 |
|
|
2022
Q3 | $1K | Sell |
231
-26,556
| -99% | -$115K | ﹤0.01% | 9080 |
|
|
2022
Q2 | $82K | Buy |
26,787
+14,200
| +113% | +$43.5K | ﹤0.01% | 4575 |
|
|
2022
Q1 | $85K | Sell |
12,587
-10,490
| -45% | -$70.8K | ﹤0.01% | 5033 |
|
|
2021
Q4 | $193K | Buy |
23,077
+11,753
| +104% | +$98.3K | ﹤0.01% | 4692 |
|
|
2021
Q3 | $84K | Sell |
11,324
-6,997
| -38% | -$51.9K | ﹤0.01% | 4873 |
|
|
2021
Q2 | $125K | Sell |
18,321
-1,062
| -5% | -$7.25K | ﹤0.01% | 4684 |
|
|
2021
Q1 | $199K | Buy |
19,383
+15,280
| +372% | +$157K | ﹤0.01% | 4523 |
|
|
2020
Q4 | $29K | Buy |
4,103
+3,334
| +434% | +$23.6K | ﹤0.01% | 5666 |
|
|
2020
Q3 | $6K | Sell |
769
-4,691
| -86% | -$36.6K | ﹤0.01% | 6376 |
|
|
2020
Q2 | $38K | Sell |
5,460
-9,142
| -63% | -$63.6K | ﹤0.01% | 5268 |
|
|
2020
Q1 | $69K | Sell |
14,602
-5,793
| -28% | -$27.4K | ﹤0.01% | 4705 |
|
|
2019
Q4 | $178K | Buy |
20,395
+7,915
| +63% | +$69.1K | ﹤0.01% | 4668 |
|
|
2019
Q3 | $41K | Buy |
12,480
+9,549
| +326% | +$31.4K | ﹤0.01% | 5362 |
|
|
2019
Q2 | $15K | Buy |
2,931
+628
| +27% | +$3.21K | ﹤0.01% | 5949 |
|
|
2019
Q1 | $14K | Sell |
2,303
-4,399
| -66% | -$26.7K | ﹤0.01% | 5775 |
|
|
2018
Q4 | $22K | Buy |
6,702
+2,461
| +58% | +$8.08K | ﹤0.01% | 5798 |
|
|
2018
Q3 | $28K | Buy |
4,241
+3,991
| +1,596% | +$26.3K | ﹤0.01% | 5691 |
|
|
2018
Q2 | $2K | Sell |
250
-1,081
| -81% | -$8.65K | ﹤0.01% | 6819 |
|
|
2018
Q1 | $30K | Buy |
1,331
+17
| +1% | +$383 | ﹤0.01% | 5231 |
|
|
2017
Q4 | $17K | Buy |
1,314
+950
| +261% | +$12.3K | ﹤0.01% | 5721 |
|
|
2017
Q3 | $6K | Buy |
+364
| New | +$6K | ﹤0.01% | 6248 |
|
|
2017
Q2 | – | Sell |
-1,110
| Closed | -$24K | – | 6933 |
|
|
2017
Q1 | $24K | Buy |
+1,110
| New | +$24K | ﹤0.01% | 5115 |
|